Statement of Changes in Beneficial Ownership (4)
March 17 2021 - 6:53PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Millner F. Ann |
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC
[
MMSI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
1600 WEST MERIT PARKWAY |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/15/2021 |
(Street)
SOUTH JORDAN, UT 84095
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, No Par Value | 3/15/2021 | | M | | 4246 | A | $21.98 | 15476 | D | |
Common Stock, No Par Value | 3/15/2021 | | F | | 1552 | D | $60.15 | 13924 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-qualified stock options (right to buy) | $21.98 | 3/15/2021 | | M/K | | | 4246 (1) | 7/16/2016 (2) | 7/16/2022 | Common Stock | 4246 (1) | $0 | 0 | D | |
Restricted Stock Unit | (3) | | | | | | | (3) | 6/22/2021 | Common Stock | 4188 | | 4188 | D | |
Non-qualified stock options (right to buy) | $18.8 | | | | | | | 5/26/2017 (4) | 5/26/2023 | Common Stock | 10000 | | 10000 | D | |
Non-qualified stock options (right to buy) | $34.4 | | | | | | | 5/24/2018 (5) | 5/24/2024 | Common Stock | 20000 | | 20000 | D | |
Non-qualified stock options (right to buy) | $50.5 | | | | | | | 6/7/2019 (6) | 6/7/2025 | Common Stock | 25000 | | 25000 | D | |
Non-qualified stock options (right to buy) | $52.17 | | | | | | | 5/24/2020 (7) | 5/24/2026 | Common Stock | 13750 | | 13750 | D | |
Non-qualified stock options (right to buy) | $52.17 | | | | | | | 5/31/2020 (8) | 5/31/2026 | Common Stock | 7500 | | 7500 | D | |
Explanation of Responses: |
(1) | In the Reporting Person's Form 4 filed on June 24, 2020, the number of these options was incorrectly listed at 4,264 when the correct number of options was 4,246. |
(2) | Becomes exercisable in equal annual installments of 20% commencing 07/16/2016. |
(3) | Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. |
(4) | Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. |
(5) | Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. |
(6) | Becomes exercisable in equal annual installments of 20% commencing 06/07/2019. |
(7) | Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. |
(8) | Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Millner F. Ann 1600 WEST MERIT PARKWAY SOUTH JORDAN, UT 84095 | X |
|
|
|
Signatures
|
/s/ Brian G. Lloyd, Attorney-in-Fact | | 3/17/2021 |
**Signature of Reporting Person | Date |
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Sep 2023 to Sep 2024